Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves
10.1056/nejmoa1509233 · 2015
Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study
10.1016/s0140-6736(17)30757-2 · 2017
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves
10.1016/j.jacc.2020.04.043 · 2020
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
10.1056/nejmoa1911426 · 2020
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy
2022
Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis
10.1016/j.jcmg.2017.02.005 · 2017
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research
10.1093/eurheartj/ehaa799 · 2021
Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?
10.3389/fcvm.2019.00044 · 2019
Subclinical Leaflet Thrombosis and Subclinical Aortic Valve Complex Thrombosis in TAVR
10.1016/j.jacadv.2025.102085 · 2025
The Fluid Mechanics of Transcatheter Heart Valve Leaflet Thrombosis in the Neosinus
10.1161/circulationaha.117.029479 · 2017
Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studies
10.4244/eij-d-17-01062 · 2018
The risk of valve thrombosis is higher with intra-annular versus supra-annular transcatheter aortic valve prosthesis. A meta-analysis from randomized controlled trials
10.1007/s00392-021-01818-x · 2021
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis
10.1016/j.jcin.2021.09.019 · 2021
Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves
10.4244/eij-d-17-00373 · 2017
Commissural misalignment independently predicts leaflet thrombosis after transcatheter aortic valve implantation
10.1007/s00392-023-02192-6 · 2024
Hypoattenuated Leaflet Thickening, Hemodynamics, and Hemorrhage: Is It Time to Personalize Anticoagulation After Transcatheter Aortic Valve Implant?
2026
Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement
10.1016/j.jcin.2022.04.018 · 2022
Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration
10.1016/j.jcmg.2018.06.028 · 2019
Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening
10.1161/circinterventions.124.014523 · 2025
Durability of transcatheter aortic valve implantation
10.4244/eij-d-23-01050 · 2024
Temporal trends of aortic valve replacement modalities by age group in the United-States 2015 - 2023
10.1093/eurheartj/ehae666.2459 · 2024
Is bioprosthetic leaflet thrombosis a trigger to valve degeneration?
10.1136/heartjnl-2017-312861 · 2018
Detection and Prediction of Bioprosthetic Aortic Valve Degeneration
10.1016/j.jacc.2018.12.056 · 2019
Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation
10.1161/circulationaha.121.056891 · 2021
Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovasc
10.1016/j.echo.2023.10.004 · 2024
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interve
10.1093/ejcts/ezx244 · 2017
Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration
10.1016/j.jacc.2017.07.715 · 2017
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial
10.1093/eurheartj/ehae043 · 2024
Impact of Anticoagulation on Long-term Bioprosthesis Durability After Transcatheter Aortic Valve Replacement
2025
Long-Term Durability of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Systematic Review and Meta-Analysis
2025
Leaflet Mechanical Stress in Different Designs and Generations of Transcatheter Aortic Valves: An in Vitro Study
2024
Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry
2023
Long-Term Functional and Structural Durability of Bioprosthetic Valves Placed in the Aortic Valve Position via Percutaneous Rout in Israel
10.1016/j.amjcard.2019.08.043 · 2019
Echocardiographic Versus Invasive Aortic Valve Gradients in Different Clinical Scenarios
10.1016/j.echo.2023.06.016 · 2023
Valvular 18F-Fluoride and 18F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients with Aortic Stenosis
10.1016/j.jacc.2015.06.1325 · 2015
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
10.1056/nejmoa1816885 · 2019
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
10.1056/nejmoa1814052 · 2019
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis
10.1056/nejmoa2400685 · 2024
Percutaneous and surgical management of aortic stenosis in the SWEDEHEART registry (2013–2023): a nationwide observational study
2026
